Vitamin Shoppe Inc (VSI) to Post FY2020 Earnings of $0.50 Per Share, Gabelli Forecasts
Vitamin Shoppe Inc (NYSE:VSI) – Analysts at Gabelli lifted their FY2020 earnings per share estimates for Vitamin Shoppe in a research report issued to clients and investors on Thursday, November 8th. Gabelli analyst D. Witkowski now forecasts that the specialty retailer will post earnings of $0.50 per share for the year, up from their prior estimate of $0.45. Gabelli also issued estimates for Vitamin Shoppe’s FY2021 earnings at $0.80 EPS and FY2022 earnings at $1.10 EPS.
VSI has been the subject of several other reports. Zacks Investment Research raised Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, August 1st. ValuEngine cut Vitamin Shoppe from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 14th. Morgan Stanley began coverage on Vitamin Shoppe in a research report on Monday, September 17th. They issued an “equal weight” rating and a $14.00 price objective for the company. Finally, Barclays cut Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a research report on Friday, September 7th.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, November 7th. The specialty retailer reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.08. Vitamin Shoppe had a positive return on equity of 3.48% and a negative net margin of 1.41%. The firm had revenue of $276.64 million during the quarter, compared to analysts’ expectations of $278.79 million.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its position in shares of Vitamin Shoppe by 10.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock valued at $7,288,000 after buying an additional 158,123 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Vitamin Shoppe in the first quarter valued at approximately $1,628,000. FMR LLC lifted its position in shares of Vitamin Shoppe by 49.7% in the second quarter. FMR LLC now owns 1,624,543 shares of the specialty retailer’s stock valued at $11,290,000 after buying an additional 539,100 shares during the last quarter. GMT Capital Corp acquired a new stake in shares of Vitamin Shoppe in the second quarter valued at approximately $7,991,000. Finally, California Public Employees Retirement System lifted its position in shares of Vitamin Shoppe by 5.0% in the first quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock valued at $1,230,000 after buying an additional 13,338 shares during the last quarter. 89.24% of the stock is owned by institutional investors.
In other Vitamin Shoppe news, CEO Sharon M. Leite acquired 5,500 shares of the business’s stock in a transaction dated Friday, August 31st. The stock was bought at an average cost of $12.64 per share, with a total value of $69,520.00. Following the completion of the transaction, the chief executive officer now directly owns 5,500 shares in the company, valued at approximately $69,520. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 18.50% of the company’s stock.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Further Reading: Understanding each part of a balance sheet
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.